Can Transcranial Electrical Stimulation enhance working memory in schizophrenia and healthy controls?
- Conditions
- Schizophrenia / Schizoaffective disorderMental Health - Schizophrenia
- Registration Number
- ACTRN12612000217808
- Lead Sponsor
- Dr. Kate Hoy
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 40
Participants with schizophrenia will be included if they:
- are voluntary and competent to consent
- have a diagnosis of Schizophrenia or Schizoaffective Disorder as confirmed by the Structure Clinical Interview for the DSM-IV (SCID-IV)
Healthy individuals will be included if they:
- have capacity to consent
- have no personal history of psychiatric illness (lifetime) - based on self report.
Patients with schizophrenia will be excluded if they:
- have a a DSM-IV history of substance abuse or dependence in the last 6 months
- have a concomitant major and/or unstable medical or neurologic illness
- are currently taking carbamazepine
- are currently pregnant or lactating
- have metal anywhere in the head, except the mouth (this includes metallic objects such as screws and clips from surgical procedures)
Healthy participants will be excluded if they:
- have an unstable medical condition, neurological disorder or are currently pregnant or lactating
- have metal in the cranium, a pacemaker, cochlear implant medication pump or other electronic device
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method A statistically significant improvement in performance on a working memory task (i.e. N-Back) following application of tDCS/tACS stimulation, both in patients with schizophrenia/ schizoaffective disorder and in healthy controls.[Before and after application of tDCS/tACS stimulation];A statistically significant improvement in performance on the N-Back working memory task following application of anodal tDCS or tACS stimulation, compared with sham stimulation, both in patients with schizophrenia/ schizoaffective disorder and in healthy controls.[Comparison of conditions - Session 1 vs Session 2 vs Session 3.<br><br>Participants' performance on the N-Back task will be measured for each session, both during and immediately after tDCS/tACS/sham stimulation. At the end of the trial, a final analysis will be conducted to compare participants' performance on the N-back across the three stimulation conditions.]
- Secondary Outcome Measures
Name Time Method il[Nil]